These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8808210)

  • 1. Increased renal expression of cytokines and growth factors induced by DOCA-NaCl treatment in Heymann nephritis.
    Tikkanen I; Uhlenius N; Tikkanen T; Miettinen A; Törnroth T; Fyhrquist F; Holthöfer H
    Nephrol Dial Transplant; 1995 Dec; 10(12):2192-8. PubMed ID: 8808210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heymann nephritis-DOCA-NaCl hypertension in the rat. Role of nephritis, DOCA, NaCl, and vascular lesions in the development of hypertension.
    Tikkanen I; Törnroth T; Miettinen A; Fyhrquist F
    Nephron; 1981; 28(2):90-5. PubMed ID: 7290277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and progression of experimental nephritis. Interaction between immunological and haemodynamic factors.
    Tikkanen I; Miettinen A; Törnroth T; Fyhrquist F
    Scand J Urol Nephrol Suppl; 1985; 90():45-50. PubMed ID: 3912983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephritis blunts urinary kallikrein excretion and aggravates DOCA/NaCl hypertension in rats.
    Prado EB; Prado MJ; Marcondes M
    Braz J Med Biol Res; 1988; 21(5):919-25. PubMed ID: 3248240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous immune complex nephritis and DOCA-NaCl load: a new model of hypertension.
    Tikkanen I; Fyhrquist F; Miettinen A; Törnroth T
    Acta Pathol Microbiol Scand A; 1980 Jul; 88(4):241-50. PubMed ID: 6449827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different blood pressure response to DOCA-NaCl treatment in autoimmune and N,N'- diacetylbenzidine-induced nephropathies.
    Tikkanen I
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):193-7. PubMed ID: 7315356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats.
    Bae EH; Kim IJ; Ma SK; Kim SW
    Hypertens Res; 2010 Mar; 33(3):255-62. PubMed ID: 20057489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats.
    Bae EH; Kim IJ; Park JW; Ma SK; Lee JU; Kim SW
    Nephrol Dial Transplant; 2010 Apr; 25(4):1051-9. PubMed ID: 19948880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension.
    Ndisang JF; Jadhav A
    J Pharmacol Exp Ther; 2010 Jul; 334(1):87-98. PubMed ID: 20392817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renoprotective effects of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis.
    Uhlenius N; Tikkanen T; Miettinen A; Holthöfer H; Törnroth T; Eriksson A; Fyhrquist F; Tikkanen I
    Nephron; 1999 Feb; 81(2):221-9. PubMed ID: 9933759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of hypertension on the progression of experimental autologous immune complex nephritis.
    Okuda S; Onoyama K; Fujimi S; Oh Y; Nomoto K; Omae T
    J Lab Clin Med; 1983 Mar; 101(3):461-71. PubMed ID: 6219170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renovascular hypertension does not influence repair of glomerular lesions induced by anti-thymocyte glomerulonephritis.
    Wenzel UO; Wolf G; Thaiss F; Helmchen U; Stahl RA
    Kidney Int; 2000 Sep; 58(3):1135-47. PubMed ID: 10972677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of hypertension on glomerular structures and capillary permeability in passive Heymann glomerulonephritis.
    Iversen BM; Ofstad J
    Microvasc Res; 1987 Sep; 34(2):137-51. PubMed ID: 3670111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DOCA/NaCl-induced chronic kidney disease: a comparison of renal nitric oxide production in resistant and susceptible rat strains.
    Erdely A; Freshour G; Tain YL; Engels K; Baylis C
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F192-6. PubMed ID: 16896184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inhibition of nitric oxide synthase in Heymann nephritis.
    Uhlenius N; Tikkanen I; Tikkanen T; Miettinen A; Törnroth T; Fyhrquist F
    Nephron; 1996; 74(1):144-9. PubMed ID: 8883033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice.
    Hartner A; Cordasic N; Klanke B; Veelken R; Hilgers KF
    Nephrol Dial Transplant; 2003 Oct; 18(10):1999-2004. PubMed ID: 13679473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous one-kidney rats are more susceptible to develop hypertension by DOCA-NaCl and subsequent kidney injury compared with uninephrectomized rats.
    Wang X; Johnson AC; Sasser JM; Williams JM; Solberg Woods LC; Garrett MR
    Am J Physiol Renal Physiol; 2016 May; 310(10):F1054-64. PubMed ID: 26936874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria.
    Hara M; Batsford SR; Mihatsch MJ; Bitter-Suermann D; Vogt A
    Lab Invest; 1991 Aug; 65(2):168-79. PubMed ID: 1881120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.